Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?Zacks Investment Research • 06/24/24
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewsWire • 05/30/24
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in ChinaGlobeNewsWire • 05/28/24
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis SystemsGlobeNewsWire • 05/20/24
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/24
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and EuropeGlobeNewsWire • 04/30/24
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024GlobeNewsWire • 04/29/24
Cytek Biosciences (CTKB) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 04/26/24
Cytek Biosciences (CTKB) Loses -7.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 04/11/24
Wall Street Analysts Believe Cytek Biosciences (CTKB) Could Rally 47.61%: Here's is How to TradeZacks Investment Research • 04/10/24
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis SolutionsGlobeNewsWire • 03/07/24
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookGlobeNewsWire • 02/28/24
Earnings Preview: Cytek Biosciences, Inc. (CTKB) Q4 Earnings Expected to DeclineZacks Investment Research • 02/21/24
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024GlobeNewsWire • 02/07/24
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific DiscoveriesGlobeNewsWire • 01/17/24
Cytek Biosciences, Inc. (CTKB) Surges 10.3%: Is This an Indication of Further Gains?Zacks Investment Research • 01/09/24